Abstract
MicroRNAs (miRNAs) are single-stranded non-coding RNAs with the ability to regulate gene expression at post-transcriptional level. Typically, miRNAs function by binding to the 3’ untranslated regions (UTR) of target mRNAs, leading to the degradation or repressed expression of target genes. It is estimated that miRNAs are involved in almost every genetic pathway and the regulation of miRNAs plays important roles in physiological and pathological processes. Small molecules that can regulate miRNAs have great potential as probes to explore miRNAs-mediated regulatory network. Small-molecule regulators of disease-related miRNAs also hold the potential as novel therapeutic agents. Based on the screening systems developed in recent years, several small-molecule regulators have been identified as specific or universal regulators of miRNAs. Therapeutic potentials of these small molecules have also been demonstrated. A general review on the reported small molecules modulating the biogenesis or function of miRNAs will be presented in this paper, with emphasis on the screening methods, proposed mechanism of action and the therapeutic potentials of these small molecules.
Keywords: miRNA, small molecules, specificity, inhibitor, activator, therapeutics.
Current Medicinal Chemistry
Title:Small Molecules Modulating Biogenesis or Processing of microRNAs with Therapeutic Potentials
Volume: 20 Issue: 29
Author(s): J. Li, W. Zhang, M. Zhou, R. Kooger and Y. Zhang
Affiliation:
Keywords: miRNA, small molecules, specificity, inhibitor, activator, therapeutics.
Abstract: MicroRNAs (miRNAs) are single-stranded non-coding RNAs with the ability to regulate gene expression at post-transcriptional level. Typically, miRNAs function by binding to the 3’ untranslated regions (UTR) of target mRNAs, leading to the degradation or repressed expression of target genes. It is estimated that miRNAs are involved in almost every genetic pathway and the regulation of miRNAs plays important roles in physiological and pathological processes. Small molecules that can regulate miRNAs have great potential as probes to explore miRNAs-mediated regulatory network. Small-molecule regulators of disease-related miRNAs also hold the potential as novel therapeutic agents. Based on the screening systems developed in recent years, several small-molecule regulators have been identified as specific or universal regulators of miRNAs. Therapeutic potentials of these small molecules have also been demonstrated. A general review on the reported small molecules modulating the biogenesis or function of miRNAs will be presented in this paper, with emphasis on the screening methods, proposed mechanism of action and the therapeutic potentials of these small molecules.
Export Options
About this article
Cite this article as:
Li J., Zhang W., Zhou M., Kooger R. and Zhang Y., Small Molecules Modulating Biogenesis or Processing of microRNAs with Therapeutic Potentials, Current Medicinal Chemistry 2013; 20 (29) . https://dx.doi.org/10.2174/0929867311320290006
DOI https://dx.doi.org/10.2174/0929867311320290006 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cosmeceutical Aptitudes of Azelaic Acid
Current Drug Research Reviews Transient Receptor Potential Channels and Dermatological Disorders
Current Topics in Medicinal Chemistry Applications of Computed Tomography, Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy for Planning External Beam Radiotherapy
Current Medical Imaging Epigenetic Modulators as Treatment Alternative to Diverse Types of Cancer
Current Medicinal Chemistry Role of Chemokines and Their Receptors in Cancer
Current Pharmaceutical Design Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer
Current Cancer Drug Targets Regulation by IFN-α/IFN-γ Co-Formulation (HerberPAG<sup>®</sup>) of Genes Involved in Interferon-STAT-Pathways and Apoptosis in U87MG
Current Topics in Medicinal Chemistry Nuclear Magnetic Resonance Spectroscopy of Lipids in Cancer
Current Organic Chemistry Pharmacological Modulation of Caspase Activation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Update on Laser Photochemotherapy: An Alternative for Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry The Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness
Current Drug Targets Inhibition of Apoptosis in Pediatric Cancer by Survivin
Current Pediatric Reviews Microdissection and the Study of Cancer Pathways
Current Molecular Medicine Epithelial-Mesenchymal Plasticity of Breast Cancer Stem Cells: Implications for Metastasis and Therapeutic Resistance
Current Pharmaceutical Design Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant Gliomas
Current Cancer Drug Targets Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
Current Medicinal Chemistry Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy
Current Cancer Drug Targets The CLCA Gene Family A Novel Family of Putative Chloride Channels
Current Genomics Cancer Gene Therapy with Tissue Inhibitors of Metalloproteinases (TIMPs)
Current Gene Therapy State of Research Tracks and Property Protection of Photodynamic Sensitizers and Delivery Methodologies
Recent Patents on Chemical Engineering